Oramed Pharmaceuticals Inc. (ORMP.OB) Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
6/3/2013 6:36:20 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JERUSALEM, June 3, 2013 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its abstract, titled "Decreased CRP levels in response to a six-week, once-daily oral insulin regimen" has been selected for a poster presentation at the 81st European Atherosclerosis Society (EAS) Congress being held on June 2-5 in Lyon, France.
Help employers find you! Check out all the jobs and post your resume.
comments powered by